451 related articles for article (PubMed ID: 18375470)
1. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.
Ding X; Chen M; Huang S; Zhang S; Zou X
Gastrointest Endosc; 2012 Dec; 76(6):1152-9. PubMed ID: 23164513
[TBL] [Abstract][Full Text] [Related]
4. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis.
Dai HF; Wang XW; Zhao K
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):11-6. PubMed ID: 19208508
[TBL] [Abstract][Full Text] [Related]
5. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
6. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
[TBL] [Abstract][Full Text] [Related]
7. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
[TBL] [Abstract][Full Text] [Related]
9. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
[TBL] [Abstract][Full Text] [Related]
10. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
[TBL] [Abstract][Full Text] [Related]
11. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
12. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
[TBL] [Abstract][Full Text] [Related]
13. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Sun HL; Han B; Zhai HP; Cheng XH; Ma K
Surgeon; 2014 Jun; 12(3):141-7. PubMed ID: 24332479
[TBL] [Abstract][Full Text] [Related]
14. Can wire-guided cannulation reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis? A meta-analysis of randomized controlled trials.
Shao LM; Chen QY; Chen MY; Cai JT
J Gastroenterol Hepatol; 2009 Nov; 24(11):1710-5. PubMed ID: 20136957
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
Li L; Han Z; Yuan H; Zhang G; Jia Y; He C
J Hepatobiliary Pancreat Sci; 2017 Sep; 24(9):520-529. PubMed ID: 28681997
[TBL] [Abstract][Full Text] [Related]
16. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis.
Zheng MH; Xia HH; Chen YP
Gut; 2008 Nov; 57(11):1632-3. PubMed ID: 18941015
[No Abstract] [Full Text] [Related]
17. Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis.
Bang UC; Nøjgaard C; Andersen PK; Matzen P
Aliment Pharmacol Ther; 2009 May; 29(10):1078-85. PubMed ID: 19236312
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
Li X; Tao LP; Wang CH
World J Gastroenterol; 2014 Sep; 20(34):12322-9. PubMed ID: 25232268
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses.
Zhang Y; Chen QB; Gao ZY; Xie WF
Aliment Pharmacol Ther; 2009 Jun; 29(11):1155-64. PubMed ID: 19302265
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
